Copyright Reports & Markets. All rights reserved.

Global Surgical Anti-Adhesion Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Surgical Anti-Adhesion Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Surgical Anti-Adhesion Market Size Growth Rate by Product
      • 1.4.2 Gels
      • 1.4.3 Films
    • 1.5 Market by End User
      • 1.5.1 Global Surgical Anti-Adhesion Market Size Growth Rate by End User
      • 1.5.2 General/abdominal Surgery
      • 1.5.3 Pelvic/gynecological Surgery
      • 1.5.4 Other Surgery
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Surgical Anti-Adhesion Market Size
      • 2.1.1 Global Surgical Anti-Adhesion Revenue 2014-2025
      • 2.1.2 Global Surgical Anti-Adhesion Sales 2014-2025
    • 2.2 Surgical Anti-Adhesion Growth Rate by Regions
      • 2.2.1 Global Surgical Anti-Adhesion Sales by Regions
      • 2.2.2 Global Surgical Anti-Adhesion Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Surgical Anti-Adhesion Sales by Manufacturers
      • 3.1.1 Surgical Anti-Adhesion Sales by Manufacturers
      • 3.1.2 Surgical Anti-Adhesion Sales Market Share by Manufacturers
      • 3.1.3 Global Surgical Anti-Adhesion Market Concentration Ratio (CR5 and HHI)
    • 3.2 Surgical Anti-Adhesion Revenue by Manufacturers
      • 3.2.1 Surgical Anti-Adhesion Revenue by Manufacturers (2014-2019)
      • 3.2.2 Surgical Anti-Adhesion Revenue Share by Manufacturers (2014-2019)
    • 3.3 Surgical Anti-Adhesion Price by Manufacturers
    • 3.4 Surgical Anti-Adhesion Manufacturing Base Distribution, Product Types
      • 3.4.1 Surgical Anti-Adhesion Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Surgical Anti-Adhesion Product Type
      • 3.4.3 Date of International Manufacturers Enter into Surgical Anti-Adhesion Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Surgical Anti-Adhesion Sales by Product
    • 4.2 Global Surgical Anti-Adhesion Revenue by Product
    • 4.3 Surgical Anti-Adhesion Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Surgical Anti-Adhesion Breakdown Data by End User

    6 North America

    • 6.1 North America Surgical Anti-Adhesion by Countries
      • 6.1.1 North America Surgical Anti-Adhesion Sales by Countries
      • 6.1.2 North America Surgical Anti-Adhesion Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Surgical Anti-Adhesion by Product
    • 6.3 North America Surgical Anti-Adhesion by End User

    7 Europe

    • 7.1 Europe Surgical Anti-Adhesion by Countries
      • 7.1.1 Europe Surgical Anti-Adhesion Sales by Countries
      • 7.1.2 Europe Surgical Anti-Adhesion Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Surgical Anti-Adhesion by Product
    • 7.3 Europe Surgical Anti-Adhesion by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Surgical Anti-Adhesion by Countries
      • 8.1.1 Asia Pacific Surgical Anti-Adhesion Sales by Countries
      • 8.1.2 Asia Pacific Surgical Anti-Adhesion Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Surgical Anti-Adhesion by Product
    • 8.3 Asia Pacific Surgical Anti-Adhesion by End User

    9 Central & South America

    • 9.1 Central & South America Surgical Anti-Adhesion by Countries
      • 9.1.1 Central & South America Surgical Anti-Adhesion Sales by Countries
      • 9.1.2 Central & South America Surgical Anti-Adhesion Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Surgical Anti-Adhesion by Product
    • 9.3 Central & South America Surgical Anti-Adhesion by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Surgical Anti-Adhesion by Countries
      • 10.1.1 Middle East and Africa Surgical Anti-Adhesion Sales by Countries
      • 10.1.2 Middle East and Africa Surgical Anti-Adhesion Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Surgical Anti-Adhesion by Product
    • 10.3 Middle East and Africa Surgical Anti-Adhesion by End User

    11 Company Profiles

    • 11.1 Ethicon
      • 11.1.1 Ethicon Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Ethicon Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Ethicon Surgical Anti-Adhesion Products Offered
      • 11.1.5 Ethicon Recent Development
    • 11.2 SANOFI
      • 11.2.1 SANOFI Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 SANOFI Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 SANOFI Surgical Anti-Adhesion Products Offered
      • 11.2.5 SANOFI Recent Development
    • 11.3 Baxter International
      • 11.3.1 Baxter International Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Baxter International Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Baxter International Surgical Anti-Adhesion Products Offered
      • 11.3.5 Baxter International Recent Development
    • 11.4 Pathfinder Cell Therapy
      • 11.4.1 Pathfinder Cell Therapy Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Pathfinder Cell Therapy Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Pathfinder Cell Therapy Surgical Anti-Adhesion Products Offered
      • 11.4.5 Pathfinder Cell Therapy Recent Development
    • 11.5 Covidien
      • 11.5.1 Covidien Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Covidien Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Covidien Surgical Anti-Adhesion Products Offered
      • 11.5.5 Covidien Recent Development
    • 11.6 Integra Life Sciences
      • 11.6.1 Integra Life Sciences Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Integra Life Sciences Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Integra Life Sciences Surgical Anti-Adhesion Products Offered
      • 11.6.5 Integra Life Sciences Recent Development
    • 11.7 FzioMed
      • 11.7.1 FzioMed Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 FzioMed Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 FzioMed Surgical Anti-Adhesion Products Offered
      • 11.7.5 FzioMed Recent Development
    • 11.8 Anika Therapeutics
      • 11.8.1 Anika Therapeutics Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Anika Therapeutics Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Anika Therapeutics Surgical Anti-Adhesion Products Offered
      • 11.8.5 Anika Therapeutics Recent Development
    • 11.9 Bioscompass
      • 11.9.1 Bioscompass Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bioscompass Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bioscompass Surgical Anti-Adhesion Products Offered
      • 11.9.5 Bioscompass Recent Development
    • 11.10 Shanghai Haohai
      • 11.10.1 Shanghai Haohai Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Shanghai Haohai Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Shanghai Haohai Surgical Anti-Adhesion Products Offered
      • 11.10.5 Shanghai Haohai Recent Development
    • 11.11 SJZ Yishengtang
    • 11.12 Singclean Medical
    • 11.13 SJZ Ruinuo
    • 11.14 HK Wellife

    12 Future Forecast

    • 12.1 Surgical Anti-Adhesion Market Forecast by Regions
      • 12.1.1 Global Surgical Anti-Adhesion Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Surgical Anti-Adhesion Revenue Forecast by Regions 2019-2025
    • 12.2 Surgical Anti-Adhesion Market Forecast by Product
      • 12.2.1 Global Surgical Anti-Adhesion Sales Forecast by Product 2019-2025
      • 12.2.2 Global Surgical Anti-Adhesion Revenue Forecast by Product 2019-2025
    • 12.3 Surgical Anti-Adhesion Market Forecast by End User
    • 12.4 North America Surgical Anti-Adhesion Forecast
    • 12.5 Europe Surgical Anti-Adhesion Forecast
    • 12.6 Asia Pacific Surgical Anti-Adhesion Forecast
    • 12.7 Central & South America Surgical Anti-Adhesion Forecast
    • 12.8 Middle East and Africa Surgical Anti-Adhesion Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Surgical Anti-Adhesion Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Surgical Anti-Adhesion market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Surgical Anti-Adhesion market based on company, product type, end user and key regions.

      This report studies the global market size of Surgical Anti-Adhesion in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Surgical Anti-Adhesion in these regions.
      This research report categorizes the global Surgical Anti-Adhesion market by top players/brands, region, type and end user. This report also studies the global Surgical Anti-Adhesion market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Ethicon
      SANOFI
      Baxter International
      Pathfinder Cell Therapy
      Covidien
      Integra Life Sciences
      FzioMed
      Anika Therapeutics
      Bioscompass
      Shanghai Haohai
      SJZ Yishengtang
      Singclean Medical
      SJZ Ruinuo
      HK Wellife

      Market size by Product
      Gels
      Films
      Market size by End User
      General/abdominal Surgery
      Pelvic/gynecological Surgery
      Other Surgery

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Surgical Anti-Adhesion market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Surgical Anti-Adhesion market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Surgical Anti-Adhesion companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Surgical Anti-Adhesion submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Surgical Anti-Adhesion are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Surgical Anti-Adhesion market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now